Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of Airway Basal Stem Cells on Treatment of Pediatric Bronchiolitis Obliterans

NCT07239895 is registered in ClinicalTrials.gov with Regend Therapeutics as lead sponsor.

NCT NCT07239895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07239895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of Airway Basal Stem Cells on Treatment of Pediatric Bronchiolitis Obliterans
Lead sponsor
Regend Therapeutics
Phase
Phase 1
Overall status
Recruiting
Start date
November 11, 2025
Completion date
November 30, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric bronchiolitis obliterans